Abstract:Key PointsTwo major classes of ubiquitin ligases, the SKP1–CUL1–F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), have a central role in cell-cycle regulation.The SCF complex and APC/C are structurally similar. Each is constituted of common subunits and a variable substrate-recognition subunit (F-box proteins for the SCF complex and activators for the APC/C). Three F-box proteins in the SCF complex — S-phase kinase-associated protein 2 (SKP2), F-box and WD-40 domain protein 7 (FBW7) and β-transducin repeat-containing protein (β-TRCP) — and two activators in the APC/C — cell division cycle 20 (CDC20) and CDH1 (also known as HCT1) — are the most important in cell-cycle regulation.SKP2 targets negative regulators of the cell cycle such as p27, p21 and p57 for degradation, and thereby promotes cell-cycle progression during S and G2 phases. SKP2 is upregulated in many human cancers.FBW7 induces the degradation of positive regulators of the cell cycle, such as MYC, JUN, cyclin E and Notch. FBW7 is often mutated in a subset of human cancers.β-TRCP is a versatile F-box protein that recognizes several cell-cycle regulators — EMI1/2, WEE1A and CDC25A/B — in addition to its classical substrates, β-catenin and IκB. In some cancers, β-TRCP mutation or overexpression is found.CDC20 targets securin and mitotic cyclins for destruction, and thereby promotes sister-chromatid separation. CDC20 is the crucial mediator of the spindle checkpoint, which prevents aneuploidy and genomic instability. CDC20 is overexpressed in some cancers, although in others the CDC20 gene is mutated or deleted.CDH1 facilitates exit from M phase and maintains G1 phase by mediating the degradation of mitotic cyclins, non-CDK (cyclin-dependent kinase) mitotic kinases and some regulators of the formation of pre-replicative complexes. Deregulated expression or mutation of CDH1 as well as of most CDH1 targets have been described in human cancers.

Mechanisms and function of substrate recruitment by F-box proteins

Identification of Substrates for F-box Proteins.

The Role of Fbxo5 in the Development of Human Malignant Tumors.

The Characteristics and Roles of Β‐trcp1/2 in Carcinogenesis

The Functions and Properties of Cullin-5, a Potential Therapeutic Target for Cancers.

F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis

F-box receptor mediated control of substrate stability and subcellular location organizes cellular development of Aspergillus nidulans

CUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complex

Ubiquitin ligases: cell-cycle control and cancer

Function and regulation of F-box/WD repeat-containing protein 7

The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development

KDM2B/FBXL10 Targets C-Fos for Ubiquitylation and Degradation in Response to Mitogenic Stimulation

Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex

Genetically Engineered Mouse Models for Functional Studies of SKP1-CUL1-F-box-protein (SCF) E3 Ubiquitin Ligases

Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes

Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer

FBXO38 is dispensable for PD-1 regulation

The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase